Breast Cancer Therapy
Regulatory nodes coordinating signaling are potential breast cancer targets
Published in Cancer Weekly, March 16th, 2004
According to published research from the United States, "Blockade of the estrogen receptor (ER) with anti-estrogens and aromatase inhibitors is effective in the treatment of breast cancer. Why ER plays such a dominant role in breast cancer and represents such an excellent target remains to be defined. The ability of ER to respond to multiple inputs and to control expression of multiple downstream genes may be one of the reasons why ER is such a powerful target for breast cancer treatment."
"The recent modest performance of a number of targeted...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-03-16)
More Articles from Cancer Weekly
- Breast Cancer Prognosis
Expression of IGF-I receptor indicates poor prognosis for breast cancer - Breast Cancer Therapy
Anastrozole is alternative to tamoxifen for women with early breast cancer - Acute Myelogenous Leukemia
Antigens show promise for development of acute myeloid leukemia immunotherapy - Breast Cancer
Transgenic mouse model for breast cancer developed - Prostate Cancer Risk Factor
Insulin-like growth factor linked to prostate cancer - Acute Myelogenous Leukemia
MmTRA1b/phospholipid scramblase 1 may be a new prognostic factor for AML - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
